In-depth exploration of the pathogenesis of Nrf2/HO-1 in pediatric respiratory diseases can thus provide a molecular basis for research on targeted drug therapy and help realize the potential value of this axis in clinical drug research. Here, NFE2L2 is linked to respiratory system disorder.